96 related articles for article (PubMed ID: 10458404)
1. Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.
Birkenmeier G; Struck F; Gebhardt R
J Urol; 1999 Sep; 162(3 Pt 1):897-901. PubMed ID: 10458404
[TBL] [Abstract][Full Text] [Related]
2. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
Lilja H; Haese A; Björk T; Friedrich MG; Piironen T; Pettersson K; Huland E; Huland H
J Urol; 1999 Dec; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen triggers transformation of seminal alpha2-macroglobulin (alpha2-M) and its binding to alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein (alpha2-M-R/LRP) on human spermatozoa.
Birkenmeier G; Usbeck E; Schäfer A; Otto A; Glander HJ
Prostate; 1998 Sep; 36(4):219-25. PubMed ID: 9719021
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen forms complexes with human alpha 2-macroglobulin and binds to the alpha 2-macroglobulin receptor/LDL receptor-related protein.
Otto A; Bär J; Birkenmeier G
J Urol; 1998 Jan; 159(1):297-303. PubMed ID: 9400498
[TBL] [Abstract][Full Text] [Related]
5. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
[TBL] [Abstract][Full Text] [Related]
6. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum.
Björk T; Ljungberg B; Piironen T; Abrahamsson PA; Pettersson K; Cockett AT; Lilja H
Urology; 1998 Jan; 51(1):57-62. PubMed ID: 9457289
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin.
España F; Sánchez-Cuenca J; Estellés A; Gilabert J; Griffin JH; Heeb MJ
Clin Chem; 1996 Apr; 42(4):545-50. PubMed ID: 8605671
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
Christensson A; Laurell CB; Lilja H
Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
[TBL] [Abstract][Full Text] [Related]
9. Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, alpha2-macroglobulin, and their complexes.
Kanoh Y; Ohtani N; Ohara T; Mashiko T; Ohtani S; Egawa S; Baba S; Ohtani H
Oncol Rep; 2001; 8(3):515-9. PubMed ID: 11295072
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
[TBL] [Abstract][Full Text] [Related]
11. Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.
Hekim C; Riipi T; Zhu L; Laakkonen P; Stenman UH; Koistinen H
Prostate; 2010 Apr; 70(5):482-90. PubMed ID: 19937596
[TBL] [Abstract][Full Text] [Related]
12. Differential binding properties of human pregnancy zone protein- and alpha2-macroglobulin-proteinase complexes to low-density lipoprotein receptor-related protein.
Chiabrando GA; Vides MA; Sánchez MC
Arch Biochem Biophys; 2002 Feb; 398(1):73-8. PubMed ID: 11811950
[TBL] [Abstract][Full Text] [Related]
13. PSA forms complexes with α1-antichymotrypsin in prostate.
Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
[TBL] [Abstract][Full Text] [Related]
14. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
15. Human leptin forms complexes with alpha 2-macroglobulin which are recognized by the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein.
Birkenmeier G; Kämpfer I; Kratzsch J; Schellenberger W
Eur J Endocrinol; 1998 Aug; 139(2):224-30. PubMed ID: 9724081
[TBL] [Abstract][Full Text] [Related]
16. The disappearance of enzyme-inhibitor complexes from the circulation of man.
Ohlsson K; Laurell CB
Clin Sci Mol Med; 1976 Jul; 51(1):87-92. PubMed ID: 59654
[TBL] [Abstract][Full Text] [Related]
17. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors.
Coker CB; Coptcoat MJ; Mulvin D; Cuomo A; Scott N; Sherwood R
Br J Urol; 1998 Jan; 81(1):105-8. PubMed ID: 9467485
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
Lilja H; Cockett AT; Abrahamsson PA
Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y
BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
